1Simpson KL, Spencer CM. Insulin aspart[J]. Drugs. 1999, 57(5):759-767.
2Tamas G, Marre M, Astorga R,et al. Glycaemic control in type 1 diabetic patients using optimised insulin aspart or human insulin in a randomised multinational study[J]. Diabetes Res Clin Pract. 2001, 54(2):105-114.
3Rosenfalck AM, Thorsby P, Kjems L, et al. Improved postprandial glycaemic control with insulin Aspart in type 2 diabetic patients treated with insulin[J]. Acta Diabetol. 2000, 37(1):41-46.
4Vague P, Selam JL, Skeie S, et al. Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart[J]. Diabetes Care. 2003, 26(3):590-596.
5Heller S. Reducing hypoglycaemia with insulin analogues[J]. Int J Obes Relat Metab Disord. 2002, 26 (Suppl 3):S31-36.
6Kobayashi T. Efficacy, safety and indication of newly developed insulin analogs[J]. Nippon Rinsho,2001, 59(11):2165-2172.
